Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group-Reference-Cited by-同舟云学术

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

Published:2016-12-16 Issue:7 Volume:123 Page:1095-1105
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Burchill Susan A.¹,Beiske Klaus²,Shimada Hiroyuki³,Ambros Peter F.⁴,Seeger Robert⁵,Tytgat Godelieve A.M.⁶,Brock Penelope R.⁷,Haber Michelle⁸,Park Julie R.⁹,Berthold Frank¹⁰

Affiliation:

1. Children's Cancer Research Group, Leeds Institute of Cancer and Pathology, St James's University Hospital; Leeds United Kingdom

2. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital; Oslo Norway

3. Department of Pathology and Laboratory Medicine; Children's Hospital Los Angeles; Los Angeles California

4. CCRI; Children's Cancer Research Institute; Vienna Austria

5. The Saban Research Institute; Children's Hospital Los Angeles; Los Angeles California

6. Princess Maxima Center for Pediatric Oncology; Utrecht The Netherlands

7. Great Ormond Street Hospital for Children NHS Trust; London United Kingdom

8. Children's Cancer Institute for Medical Research, Cancer Research Centre; Sydney New South Wales Australia

9. Department of Pediatrics; School of Medicine, University of Washington, Seattle Children's Hospital; Seattle Washington

10. Department of Pediatric Oncology and Hematology; Center for Integrated Oncology, University of Cologne; Cologne Germany

Funder

Alex's Lemonade Stand Foundation

EVAN Foundation

Ben Towne Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report;Monclair;J Clin Oncol.,2009

2. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report;Cohn;J Clin Oncol.,2009

3. Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?;Cheung;J Clin Oncol.,1997

4. Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma;Kushner;J Clin Oncol.,2009

5. Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group study;Seeger;J Clin Oncol.,2000

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation;Scientific Reports;2024-09-09

2. Whole-tumoral metabolic heterogeneity in 18F-FDG PET/CT is a novel prognostic marker for neuroblastoma;Cancer Imaging;2024-06-11

3. Normal and malignant cells are homogeneously distributed in the bone marrow of children;Leukemia & Lymphoma;2024-04-08

4. PHOX2B: a diagnostic cornerstone in neurocristopathies and neuroblastomas;Journal of Clinical Pathology;2024-03-08

5. Comprehensive review of solid tumor bone marrow metastasis;Critical Reviews in Oncology/Hematology;2024-02